Finance

Beta
Lists
CLVT:NYSE
CLARIVATE PLC
$2.41
-3.21%
(-0.080) 1D
$2.37
-1.66% (-0.040)
After hours
Closed: Jun 5, 4:00:06 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CLVT...
Open
$2.48
High
$2.53
Low
$2.38
Mkt. cap
1.54B
Avg. vol.
4.96M
Volume
4.23M
52-wk high
$4.77
52-wk low
$1.66
EPS
-$0.21
Beta
1.36
Shares outstanding
639.22M
No. of employees
12K
Open
$2.48
High
$2.53
Low
$2.38
Mkt. cap
1.54B
Avg. vol.
4.96M
Volume
4.23M
52-wk high
$4.77
52-wk low
$1.66
EPS
-$0.21
Beta
1.36
Shares outstanding
639.22M
No. of employees
12K
Analyst outlook
Analyst Ratings
Based on 5 analysts giving stock ratings to CLVT in the past 3 months
Hold
Buy
1
Hold
3
Sell
1
12 month forecast
Based on 5 Wall Street analysts offering 12 month price targets for CLVT in the last 3 months.
Highest
Current $2.41
$6.00 (+148.96%)
Average
$3.58 (+48.55%)
Lowest
$2.40 (-0.41%)
News stories
From sources across the web
Profile
Clarivate Plc is a British-American publicly traded analytics company operating a collection of subscription-based services in the areas of bibliometrics and scientometrics, business and market intelligence, and competitive profiling for pharmacy and biotech, patents, regulatory compliance, trademark protection, and domain and brand protection. Clarivate calculates the impact factor of scientific journals using data from its family of Web of Science products, including services and applications such as Publons, EndNote, and EndNote Click. Clarivate other product families are Cortellis, Decision Resources Group, CPA Global, Derwent, CompuMark, Darts-ip, and ProQuest. Clarivate formed in 2016, following the acquisition of Thomson Reuters' Intellectual Property and Science business by Onex Corporation and Baring Private Equity Asia. Since 2016, Clarivate acquired various companies, notably ProQuest in 2021. Wikipedia
About CLARIVATE PLC
CEOMatti Shem-Tov
Employees12K
FoundedOct 3, 2016
HeadquartersPhiladelphia, Pennsylvania, United States
SectorService
Websiteclarivate.com
Last report
Apr 29, 2026
Fiscal period
Q1 2026
EPS / Est. (USD)
$0.18 / $0.14
+24.83%beat
Revenue / Est. (USD)
585.50M / 569.50M
+2.81%beat
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
621.40M
623.10M
617.00M
585.50M
Cost of goods sold
203.60M
218.20M
204.80M
192.10M
Cost of revenue
203.60M
218.20M
204.80M
192.10M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
181.10M
170.00M
179.10M
176.30M
Operating expense
368.90M
364.30M
354.20M
363.80M
Total operating expenses
572.50M
582.50M
559.00M
555.90M
Operating income
48.90M
40.60M
58.00M
29.60M
Other non operating income
-
-
-
-
EBT including unusual items
-59.70M
-24.50M
-24.60M
-28.80M
EBT excluding unusual items
-50.40M
-12.60M
-4.80M
-16.80M
Income tax expense
12.30M
3.80M
-27.70M
11.40M
Effective tax rate
-20.60%
-15.51%
112.60%
-39.58%
Other operating expenses
-3.10M
2.50M
-14.00M
3.50M
Net income
-72.00M
-28.30M
3.10M
-40.20M
Net profit margin
-11.59%
-4.54%
0.50%
-6.87%
Earnings per share
0.18
0.18
0.20
0.18
Interest and investment income
-
-
-
-
Interest expense
-66.60M
-68.50M
-66.00M
-59.00M
Net interest expenses
-66.60M
-68.50M
-66.00M
-59.00M
Depreciation and amortization charges
190.90M
191.80M
189.10M
184.00M
EBITDA
239.80M
232.40M
247.10M
213.60M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer